pta20230505020
Other informations about the equity market according to article 50 WpHG
Other informations about the equity market according to article 50 WpHG
QIAGEN N.V.: Release of a capital market information
Post-admission Duties announcement
Venlo (pta020/05.05.2023/12:09 UTC+2)
Form 6-K for the quarterly period ended March 31, 2023
QIAGEN N.V. hereby announces that the Form 6-K Report of Foreign Private Issuer pursuant to rule 13a-16 OR 15d-16 of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2023, was filed with the United States Securities and Exchange Comission (SEC).
The document is now available on the website of QIAGEN:
https://s28.q4cdn.com/125951340/files/doc_financials/2023/q1/2023-Q1-6-K-Final-as-filed-05-04-2023.pdf
(end)
| Emitter: |
QIAGEN N.V. Hulsterweg 82 5912 PL Venlo Netherlands |
|
|---|---|---|
| Contact Person: | Investor Relations | |
| Phone: | +31 7735566 - 00 | |
| E-Mail: | ir@qiagen.com | |
| Website: | www.qiagen.com | |
| ISIN(s): | NL0012169213 (Share) | |
| Stock Exchange(s): | Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Hannover, Munich, Stuttgart, Tradegate | |
| Other Stock Exchanges: | NYSE, SIX, BX Swiss |